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Abstract
Background: fibromyalgia is a relatively common condition with widespread pain and pressure allodynia, but
unknown aetiology. For decades, the association between motor control strategies and chronic pain has been a
topic for debate. One long held functional neuromuscular control mechanism is differential activation between
regions within a single muscle. The aim of this study was to investigate differences in neuromuscular control, i.e.
differential activation, between myalgic trapezius in fibromyalgia patients and healthy controls.
Methods: 27 fibromyalgia patients and 30 healthy controls performed 3 minutes bilateral shoulder elevations with
different loads (0-4 Kg) with a high-density surface electromyographical (EMG) grid placed above the upper
trapezius. Differential activation was quantified by the power spectral median frequency of the difference in EMG
amplitude between the cranial and caudal parts of the upper trapezius. The average duration of the differential
activation was described by the inverse of the median frequency of the differential activations.
Results: the median frequency of the differential activations was significantly lower, and the average duration of
the differential activations significantly longer in fibromyalgia compared with controls at the two lowest load levels
(0-1 Kg) (p < 0.04), but not at the two highest load levels (2 and 4 Kg).
Conclusion: these findings illustrate a different neuromuscular control between fibromyalgia patients and healthy
controls during a low load functional task, either sustaining or resulting from the chronic painful condition. The
findings may have clinical relevance for rehabilitation strategies for fibromyalgia.
Background
Approximately 20% of the European population report
severe chronic musculoskeletal pain [1]. Ten to twenty
percent of those, that is 2-4 percent of the general
population, suffer from fibromyalgia (FM). FM is charac-
terized by a widespread pain and tenderness to pressure
(allodynia), but with unknown aetiology [2-4]. FM has
been described as a complex hyperalgesic pain syn-
drome, in which abnormalities of central sensory pro-
cessing interact with peripheral pain generators and
psycho-neuro-endocrine dysfunction [5-7].
FM patients often report pain and tenderness in the
trapezius muscle, reflected by the numerous predefined
tender points located within the muscle [8]. Moreover,
the trapezius muscle in FM has shown mitochondrial
disturbances in type-I muscle fibers (i.e., ragged-red
fibers and moth-eaten fibers), hypotrophy of type-II
fibers, reduced capillarisation [9] and altered microcircu-
lation [10,11].
In line with the disturbed microcirculation in muscles
of FM patients, elevated levels of muscle fatigue has
been reported in patients with chronic neck pain [12].
Reports of inability to relax muscle or increased muscu-
lar tension in persons with or developing trapezius
myalgia [13-17] have brought focus on the association
between neuromuscular control mechanisms and
chronic pain. Several neuromuscular control mechan-
isms are proposed to prevent continuing muscle activity,
local circulation disturbances, fatigue, high-threshold
afferent activity and pain [18]. An often discussed neu-
romuscular control mechanism is rotation or substitu-
tion of active single motor units [19,20], assumed to
prevent fatigue during prolonged contractions. Another
related neuromuscular control mechanism suggested to
prevent monotonous prolonged activation of motor
units and local fatigue is reciprocal reversals of activity * Correspondence: aho@nrcwe.dk
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any medium, provided the original work is properly cited.between regions within a single muscle, termed differen-
tial activation [21-23].
Recently, Falla and colleagues observed a relatively
higher increase in activity of the cranial compared to
the caudal part of the upper trapezius in healthy con-
trols compared to FM patients during a sustained con-
traction [24]. This finding indicates recruitment of more
motor units in the cranial part of the upper trapzius
with fatigue in FM patients compared to healthy con-
trols [24]. However, it does not provide information
whether patients with FM possess an altered neuromus-
cular control strategy involving shifts in activity between
regions within a muscle (i.e. differential activations).
The aim of this study was to examine whether neuro-
muscular control is different in patients with FM from
healthy controls with respect to differential activation
within the trapezius muscle during shoulder elevations
with low load. Such low load elevations are functional
tasks which can reveal altered neuromuscular control
mechanisms relevant for daily living activities and are
therefore of ecologic validity.
Methods
Subjects
Healthy controls
Female healthy controls (N = 30; age: 40 ± 5 years,
weight: 62.8 ± 7.3 kg, height: 168 ± 8 cm) without
ongoing acute or chronic pain were recruited through
advertisements among students and staff at the Univer-
sity Hospital of Linköping, Sweden. None of the subjects
in the control group had pain according to a rating of
pain intensity in the neck and shoulder region using a
100 mm visual analogue scale (VAS; endpoints: no pain
and maximum pain, respectively) or had a recurrent
and/or chronic pain condition.
Fibromyalgia patients (FM)
Female patients with fibromyalgia (N = 29; age: 37 ± 5
years, weight: 69.3 ± 9.5 kg, height: 166 ± 5 cm), were
recruited from the Pain and Rehabilitation Centre, Uni-
versity Hospital, Linköping, Sweden. It should be noted
that not all of these patients were able to perform all
tasks (see Results, Drop-out and activity levels at the dif-
ferent loads). The patients were offered participation in
the study after examination of medical journals, positive
response to information letter, and a phone conversation
with a physician. The patients were clinically diagnosed
according to the ACR criteria of 1990 for the classifica-
tion of fibromyalgia (FM) [25]. The mean duration of
FM was 6.6 ± 3.2 years (minimum 2 years), and the
maximum pain intensity recent week was 87 ± 13 mm
according to a 100 mm VAS. Corresponding ratings for
minimum pain intensity recent week, and average pain
intensity recent week were 25 ± 15 mm, and 50 ± 18
mm, respectively.
Basic descriptive data of the two groups of subjects (i.
e., age anthropometric data, habitual pain intensity, and
data from ultrasound recording) have been presented
previously [26].
Ethical aspects
All subjects gave written informed consent to partici-
pate. The study conformed to the Declaration of Hel-
sinki and the study protocol was approved by the local
ethics committee at Linköping University.
Ultrasound recordings
Ultrasound measurements were taken of the thickness
(mm) of the trapezius muscle and the subcutaneous soft
tissue (skin and fat tissue taken together) 2 cm lateral of
the midpoint between the seventh process of the cervi-
cal spine and the lateral part of the acromion process
using an Acuson 128XP/10 (Siemens).
Muscle contractions
The subjects performed symmetrical bilateral shoulder
elevations with different loads. The loads were applied
through the attachment of different weights on a har-
ness (Figure 1). The harness consisted of 2 belts hanging
on both shoulders on the level of the acromion to allow
attachment of the weights. One additional belt was
placed around the torso in order to fixate the other two
belts. After attaching the harness and weights, the sub-
jects were asked to lift the weights such that the
shoulders were in a horizontal plane, and to hold this
position for 3 min. Weights of 0, 1, 2, and 4 kg were
applied successively. The subjects were given 1-min rest
between each contraction. The choice of absolute
weights and not relative weights in relation to maximum
performance was based on the difficulties for obtaining
valid maximum voluntary contractions (MVC) in FM
patients due to pain and/or psychological aspects such
as fear-avoidance or kinesiophobia.
Surface EMG acquisition
Surface electromyographic (EMG) signals were recorded
using a high-density electrode-grid (modified ActiveOne,
BioSemi, Amsterdam, Netherlands) consisting of 13 by
10 active electrodes, covering 6 × 4.5 cm of the skin
surface. The base of the electrode-grid device was con-
cave and semiflexible and thereby fitted well with the
convex recordings area of the upper trapezius muscle.
The centre of the electrode grid was placed on the skin
above the right trapezius muscle in the middle of the
line between the processus spinosus of the seventh cer-
vical vertebra and the lateral edge of acromion (Figure
1). In this way, the recorded signals of all subjects were
not affected by muscle-tendon transitions and similarly
affected by the motor end plate region. To generate a
stable pressure between electrodes and the skin, the
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around the shoulder and torso of the subject. The sur-
face EMG signals were recorded from all electrodes with
a common reference on the processus spinosus of the
seventh cervical vertebra at 2048 Hz.
Surface EMG analysis - Quantification of differential
activation
The differential activation analysis was previously
described [23]. The essence of the analysis was to exam-
ine the temporal changes of the difference in myoelec-
tric activity between two regions within a muscle. While
the EMG signals were recorded using a 2-D high-density
EMG grid, a large part of the processing (most of step II
below) was undertaken in order to reduce the data to
signals originating from the caudal and cranial regions
of the trapezius muscle. Multiple channels covering a
large area were recorded to get a better estimate of the
activation of the two muscle parts [27]. In short, the
procedure involved;
I. Pre-processing: Prior to analysis, poor quality sig-
nals were omitted. The remaining signals were
high-pass filtered at 10 Hz, and bipolar spatial fil-
tering in the fiber direction (medial-lateral) was
carried out.
II. Muscle activity in the cranial - caudal direction:
Muscle activity in the caudal - cranial direction
(perpendicular to fibre orientation) was calculated
by averaging the muscle activity recorded by elec-
trodes of the grid along the fibre orientation (med-
ial - lateral), providing 10 activity signals in the
cranial caudal direction. The muscle activity level
of the EMG signals was described using the root-
mean-square (RMS), calculated in 0.5 s non-over-
lapping time-windows. In order to compare the
activity between regions within the muscle, the
muscle activity signals were de-trended and nor-
malized to their maximum (Figure 2A and 2C).
III. Activity difference: The difference in the normal-
ized muscle activity between the cranial (average
of the three most superior electrode positions)
and the caudal (average of the three most infer-
ior electrode positions) regions of the upper tra-
pezius was calculated (see Figure 2A).
IV. Median frequency and average duration of the
differential activations: Differential activation was
quantified using the power spectral median fre-
quency of the activity difference signal. The
inverse of the median frequency of the differen-
tial activations was calculated to quantify the
average duration of the differential activations.
Statistics
All statistical analyses were performed using MATLAB
(The Mathworks, Nattick, USA; version 2007b). For
variables and indices mean value with one standard
deviation (± 1 SD) are generally reported. For multiple
comparisons between the two groups, two-way analysis
of variance (ANOVA) was performed. Pair-wise compar-
isons were performed using Student’st - t e s t .Ap r o b a b i l -
ity of ≤ 0.05 (two-tailed) was used as criteria for
significance in all tests.
Results
Anthropometric data including muscle dimensions (also
reported in [26])
FM patients were significantly younger (p = 0.017) and
heavier (p = 0.005) than control subjects. The average
thickness of the trapezius muscle was similar in FM and
controls, being 11.7 ± 2.4 mm over the examination area
of the trapezius in FM and 11.6 ± 2.4 mm in CON (p =
0.937). The thickness of the superjacent tissues (skin and
subcutaneous tissue) was somewhat thicker in FM than
in controls (6.6 ± 1.6 mm over the examination area in
FM versus 5.2 ± 2.5 mm in controls; p = 0.028).
Figure 1 Experimental setup. Posterior view of a subject,
electromyographical electrode device (rectangle), and weight
harness. The centre of the electrode-device was placed in the
middle of the line between processus spinosus of the C7 vertebra
and the lateral edge of acromion. The harness was used to attach
weights symmetrically on the shoulders. Subjects performed
isometric shoulder elevation such that their shoulders were held in
the horizontal plane.
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All control subjects (N = 30) were able to perform the
contractions at the four load levels (0, 1, 2 and 4 kg) with
a duration of 3 min, and were thus included in the subse-
quent analyses. In the FM group (N = 29), 2 (6.9%), 2
(6.9%), 4 (13.8%), and 8 (27.6%) patients were not able to
perform the tasks during 3 min with the 4 different exter-
nal loads, respectively, and were therefore excluded in the
subsequent analyses for these load levels.
For all loads, the muscle activity levels averaged over
all bipolar electrode leads was lower in FM than in con-
trols (p < 0.001). More specific, the activity levels at the
4 different load levels (0, 1, 2 and 4 kg) in controls was
respectively 0.87 ± 0.37, 1.04 ± 0.50, 1.14 ± 0.51 and
1.38 ± 0.58 mV and in FM 0.54 ± 0.24, 0.57 ± 0.32, 0.68
± 0.33 and 0.82 ± 0.41 mV.
Prevalence of differential activation
Figure 2 illustrates a typical example of differential mus-
cle activation between the cranial and caudal parts of
the upper trapezius muscle with an external loading of 2
Kg from a control subject and a FM patient. As shown
in the figure, the frequency of differential activity
between the cranial and caudal parts of the trapezius
was higher in the control subject (Figure 2A and 2B)
compared to the FM patient (Figure 2C and 2D).
Accordingly, the median frequency of the differential
activation between the cranial and caudal regions of the
trapezius was higher in a typical control subject (Figure
3A) than in a typical FM patient (Figure 3B) with an
external loading of 2 Kg.
Frequency of differential activation
The median frequency of differential activation at the
two lowest load levels at the shoulders (i.e., 0 and 1 kg)
was significantly lower in FM compared with the healthy
controls (p < 0.04, Table 1, Figure 4). However, the fre-
quency of differential activation was not significantly dif-
ferent between controls and FM at the two higher load
levels (i.e., 2 and 4 Kg) (p > 0.28, Table 1, Figure 4).
Figure 2 Examples of a normalized muscle activity from a high-density EMG recording (caudal - cranial, channel 1 to 10, 5 mm’s
apart) from one healthy control (A) and one patient with fibromyalgia (C) performing a 1 kg weight of isometric shoulder elevation.
The activity difference (B and D) in normalized activity between caudal and cranial regions segments (see A right) were used to calculate the
power spectral median frequency.
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decreased with increasing loading of the neck-shoulder
region in controls, but was invariant of the external
loading in FM (Table 1).
Duration of differential activation
The average duration of differential activation at the two
lowest load levels at the shoulders (i.e., 0 and 1 kg) was
significantly lower in FM compared with the healthy
controls (p < 0.03, Table 1). However, the average dura-
tion of differential activation was not significantly differ-
ent between controls and FM at the two higher load
levels (i.e., 2 and 4 Kg) (p > 0.32, Table 1). The average
duration of differential activation did not vary with
modifying external loading of the neck-shoulder region
in neither controls nor FM (Table 1).
Discussion
The main finding of this study was the lower median
frequency of the differential activations, and thus a
longer average duration of differential activation
between the trapezius regions in fibromyalgia patients
compared with healthy controls during static shoulder
elevation with none or very low weights. These results
will be discussed in the light of mechanisms behind tra-
pezius myalgia in general, and FM in specific.
Figure 3 Examples of the power spectral density (Psd) of the differential activity signal between the cranial and caudal parts of the
trapezius and its corresponding median frequency (MDF), for a healthy control (A) and a patient with fibromyalgia (B).
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keletal pain has received clinical interest for more than
a century [28]. For example based on clinical observa-
tions that patients with myalgia have tender muscles, it
has often been assumed that a vicious circle of pain and
hyperactivity exists in chronic pain [29]. Because the
healthy controls seem to be able to utilize a redundancy
of motor unit populations more frequently through
shifting active motor unit populations than patients with
fibromyalgia, this finding fits with the Cinderella
hypothesis [30].
Already in 1922, Forbes [31] noted that subpopula-
tions of motor units within a muscle may shift on being
active (differential activation) and therefore rotate on
the loading of the muscle fibers. Shifts in activity
between motor unit subpopulations in anatomical com-
plex muscles during monotonous contractions are there-
fore considered to prevent local muscle fatigue and
muscle fiber overexertion [32]. Accordingly, subjects
with larger spatial changes in distribution of intra-mus-
cular activity within the upper trapezius are observed to
be able to sustain a static contraction for longer dura-
tion than subjects with minor spatial changes [33]. The
ability to shift activity between regions within the upper
trapezius may be a preventive mechanism for avoiding
reflexive mediated muscle hyperactivity from acute pain-
ful condition further enhancing pain and a chronic con-
dition [34]. Therefore, a longer duration of differential
activation of activity within the upper trapezius may be
an underlying neuromuscular control mechanism asso-
ciated with increased risk for acute and chronic muscu-
loskeletal symptoms. In a previous study [23], the
duration of differential activation was observed to be
positively associated with fatigue prevention. However,
this was observed at the biceps brachii during a 30 min
contraction in healthy individuals, and may therefore
not be translated to this study of the trapezius muscle
in FM and healthy controls during a 3 min contraction.
On the other hand, the reduced differential activation
in fibromyalgia patients may also be a result of the
chronic painful condition; e.g in CNS (central sensitizing
processes, alterations in function of neuromatrix of pain
in the brain or in descending inhibition) [35-38] and/or
in muscle [9-11]. This is supported by the finding that
myoelectrical manifestations of fatigue in fibromyalgia
patients are central of origin [39]. Prospective investiga-
tions of the relation between neuromuscular control
strategies and chronic pain are very few [17], and future
prospective investigations between neuromuscular con-
trol strategies and chronic pain are recommended for
elucidating the relation between neuromuscular control
and chronic myalgia.
Table 1 Median frequency and duration of differential
activation in fibromyalgia (FM) and healthy controls
(CON); mean values ± 1 standard deviation (SD) and
minimum and maximum values.
Group CON FM Statistics
Variable and
load
Mean ±
SD
Min-
Max
Mean ±
SD
Min-
Max
p-value
Frequency (s
-1)
0k g 0.43 ±
0.08
0.24-
0.56
0.37 ±
0.11
0.14-
0.53
0.028*
1k g 0.42 ±
0.10
0.23-
0.57
0.35 ±
0.12
0.12-
0.60
0.033*
2k g 0.37 ±
0.11
0.11-
0.51
0.34 ±
0.12
0.14-
0.53
0.303
4k g 0.39 ±
0.11
0.14-
0.56
0.36 ±
0.12
0.14-
0.60
0.280
Duration (sec)
0k g 1.21 ±
0.26
0.89-
2.08
1.51 ±
0.61
0.95-
3.59
0.022*
1k g 1.28 ±
0.36
0.88-
2.23
1.67 ±
0.85
0.82-
4.30
0.025*
2k g 1.57 ±
0.83
0.98-
4.60
1.71 ±
0.73
0.95-
3.59
0.500
4k g 1.42 ±
0.59
0.90-
3.59
1.59 ±
0.68
0.84-
3.58
0.325
Furthest to the right is the result of the statistical comparisons (p-values)
between groups (CON vs. FM); * denotes significant difference.
Figure 4 Mean values and 95% confidence intervals for median frequency of the differential activations for healthy controls and
patients with fibromyalgia at different weights. Furthest to the right is shown the difference between the two groups.
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partly be due to the somewhat thicker subcutaneous tis-
sue. Although a thicker subcutaneous layer can affect
EMG amplitude and the spatial distribution, it is not
likely to affect temporal fluctuations in EMG amplitude
and differential activation as investigated in the present
study. In addition, the ultrasound investigation did not
reveal any significant difference in thickness of the tra-
pezius muscle between the two groups. In order to defi-
nitely determine the level of muscle activity, an MVC is
needed. However, the validity of MVC in FM can be
questioned due to factors such as pain, increase in pain
with increasing contraction level, anxiety and different
aspects of fear and fear behaviour. However, the obser-
vation of a difference in differential activations between
FM patients and health controls at very low force levels
(0-1 Kg), but not higher force levels (2-4 Kg), supports
that a generally higher maximal strength of controls
compared with FM patients [24] is not the primary
cause to the findings of this study.
The previously documented changes in intra-muscular
activity within the upper trapezius of healthy subjects
with injection of hypertonic saline suggest that local eli-
citation of nociceptive afferents generates a reorganiza-
tion of activity within the upper trapezius [40]. The
ability of independent selective voluntary activation of
regions within the trapezius muscle with biofeedback
guidance [41] illustrates that differential activation
between regions of the upper trapezius may be a volun-
tary neuromuscular strategy.
Conclusions
For the first time, a different neuromuscular control
mechanism involving degree of shifts between regions
(differential activation) within a single muscle is
observed between fibromyalgia patients and healthy con-
trols. The lower frequency of differential activation
between regions within the upper trapezius of FM
patients than controls indicates that this may be a neu-
romuscular control strategy either sustaining or being a
result of the chronic painful condition. The findings
m a yh a v ec l i n i c a lr e l e v a n c ef o rr e h a b i l i t a t i o ns t r a t e g i e s
for fibromyalgia.
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